• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过固态 NMR 预测曲格列酮/聚乙烯吡咯烷酮固体分散体的再结晶行为。

Prediction of recrystallization behavior of troglitazone/polyvinylpyrrolidone solid dispersion by solid-state NMR.

机构信息

Formulation Technology Research Laboratories, Daiichi Sankyo Co, Ltd, 1-2-58, Hiromachi, Tokyo 140-8710, Japan.

出版信息

Int J Pharm. 2010 Jan 4;383(1-2):18-23. doi: 10.1016/j.ijpharm.2009.08.037. Epub 2009 Sep 2.

DOI:10.1016/j.ijpharm.2009.08.037
PMID:19732816
Abstract

The purpose of this study was to elaborate the relationship between the (13)C CP/MAS NMR spectra and the recrystallization behavior during the storage of troglitazone solid dispersions. The solid dispersions were prepared by either the solvent method or by co-grinding. The recrystallization behavior under storage conditions at 40 degrees C/94% RH was evaluated by the Kolmogorov-Johnson-Mehl-Avrami (KJMA) equation. Solid dispersions prepared by the solvent method or by prolonged grinding brought about inhibition of the nucleation and the nuclei growth at the same time. No differences in the PXRD profiles were found in the samples prepared by the co-grinding and solvent methods, however, (13)C CP/MAS NMR showed significant differences in the spectra. The correlation coefficients using partial least square regression analysis between the PXRD profiles and the apparent nuclei-growth constant or induction period to nucleation were 0.1305 or 0.6350, respectively. In contrast, those between the (13)C CP/MAS NMR spectra and the constant or the period were 0.9916 or 0.9838, respectively. The (13)C CP/MAS NMR spectra had good correlation with the recrystallization kinetic parameters evaluated by the KJMA equation. Consequently, solid-state NMR was judged to be a useful tool for the prediction of the recrystallization behavior of solid dispersions.

摘要

本研究旨在阐述 13C CP/MAS NMR 谱与曲格列酮固体分散体储存过程中重结晶行为之间的关系。固体分散体通过溶剂法或共研磨法制备。在 40°C/94%RH 的储存条件下,通过 Kolmogorov-Johnson-Mehl-Avrami(KJMA)方程评估重结晶行为。溶剂法或长时间研磨制备的固体分散体同时抑制成核和核生长。通过共研磨和溶剂法制备的样品在 PXRD 图谱上没有发现差异,然而,13C CP/MAS NMR 显示出谱图上的显著差异。偏最小二乘回归分析表明,PXRD 图谱与明显的核生长常数或成核诱导期之间的相关系数分别为 0.1305 或 0.6350,而 13C CP/MAS NMR 图谱与常数或周期之间的相关系数分别为 0.9916 或 0.9838。13C CP/MAS NMR 谱与通过 KJMA 方程评估的重结晶动力学参数具有良好的相关性。因此,固态 NMR 被认为是预测固体分散体重结晶行为的有用工具。

相似文献

1
Prediction of recrystallization behavior of troglitazone/polyvinylpyrrolidone solid dispersion by solid-state NMR.通过固态 NMR 预测曲格列酮/聚乙烯吡咯烷酮固体分散体的再结晶行为。
Int J Pharm. 2010 Jan 4;383(1-2):18-23. doi: 10.1016/j.ijpharm.2009.08.037. Epub 2009 Sep 2.
2
Evaluation of solid state form of troglitazone by solid state NMR spectroscopy.通过固态核磁共振光谱法评估曲格列酮的固态形式。
J Pharm Biomed Anal. 2005 Feb 7;37(1):177-81. doi: 10.1016/j.jpba.2004.09.035.
3
Effects of water content in physical mixture and heating temperature on crystallinity of troglitazone-PVP K30 solid dispersions prepared by closed melting method.物理混合物中的含水量和加热温度对采用密闭熔融法制备的曲格列酮 - PVP K30固体分散体结晶度的影响。
Int J Pharm. 2005 Sep 30;302(1-2):103-12. doi: 10.1016/j.ijpharm.2005.06.021.
4
Uniformity and physical states of troglitazone in solid dispersions determined by electron probe microanalysis and microthermal analysis.
Int J Pharm. 2004 Aug 6;280(1-2):39-46. doi: 10.1016/j.ijpharm.2004.04.024.
5
Evaluation of solid dispersions on a molecular level by the Raman mapping technique.通过拉曼映射技术在分子水平上评估固体分散体。
Int J Pharm. 2008 Sep 1;361(1-2):12-8. doi: 10.1016/j.ijpharm.2008.05.009. Epub 2008 May 16.
6
Effect of physical properties of troglitazone crystal on the molecular interaction with PVP during heating.曲格列酮晶体物理性质对加热过程中与聚乙烯吡咯烷酮分子相互作用的影响。
Int J Pharm. 2007 May 4;336(1):82-9. doi: 10.1016/j.ijpharm.2006.11.041. Epub 2006 Nov 26.
7
Use of CP/MAS solid-state NMR for the characterization of solvate molecules within estradiol crystal forms.使用交叉极化/魔角旋转(CP/MAS)固态核磁共振技术表征雌二醇晶体形式中的溶剂化分子。
Eur J Pharm Biopharm. 2005 Aug;60(3):407-12. doi: 10.1016/j.ejpb.2005.01.010.
8
The influence of povidone K17 on the storage stability of solid dispersions of nimodipine and polyethylene glycol.聚维酮K17对尼莫地平与聚乙二醇固体分散体储存稳定性的影响
Eur J Pharm Biopharm. 2007 Apr;66(1):106-12. doi: 10.1016/j.ejpb.2006.08.018. Epub 2006 Sep 10.
9
Characterization and stability of solid dispersions based on PEG/polymer blends.基于 PEG/聚合物共混物的固体分散体的特性和稳定性。
Int J Pharm. 2010 May 10;390(2):165-73. doi: 10.1016/j.ijpharm.2010.01.039. Epub 2010 Feb 10.
10
Solid dispersion of spironolactone with porous silica prepared by the solvent method.通过溶剂法制备的螺内酯与多孔二氧化硅的固体分散体。
Pharmazie. 2007 Aug;62(8):599-603.

引用本文的文献

1
Oral Bioavailability Enhancement of Poorly Soluble Drug by Amorphous Solid Dispersion Using Sucrose Acetate Isobutyrate.利用醋酸丁酸蔗糖酯无定形固体分散体提高难溶性药物的口服生物利用度。
AAPS PharmSciTech. 2024 Sep 5;25(7):202. doi: 10.1208/s12249-024-02924-5.
2
Amorphization of Low Soluble Drug with Amino Acids to Improve Its Therapeutic Efficacy: a State-of-Art-Review.氨基酸对低溶性药物进行非晶化以提高其治疗效果:综述。
AAPS PharmSciTech. 2023 Dec 7;24(8):253. doi: 10.1208/s12249-023-02709-2.
3
Amorphous Solid Dispersion as Drug Delivery Vehicles in Cancer.
无定形固体分散体作为癌症治疗中的药物递送载体
Polymers (Basel). 2023 Aug 11;15(16):3380. doi: 10.3390/polym15163380.
4
Solid-State NMR Spectroscopy: A Key Tool to Unravel the Supramolecular Structure of Drug Delivery Systems.固态核磁共振波谱学:揭示药物传递系统超分子结构的关键工具。
Molecules. 2021 Jul 7;26(14):4142. doi: 10.3390/molecules26144142.
5
Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products.无定形固体分散体:制备、表征、生物利用度机制、稳定性、监管考虑因素和上市产品的更新。
Int J Pharm. 2020 Aug 30;586:119560. doi: 10.1016/j.ijpharm.2020.119560. Epub 2020 Jun 18.
6
Stabilization of a supersaturated solution of mefenamic acid from a solid dispersion with EUDRAGIT(®) EPO.将依托泊苷固体分散体中处于过饱和状态的甲芬那酸溶液进行稳定化处理。
Pharm Res. 2012 Oct;29(10):2777-91. doi: 10.1007/s11095-011-0655-7. Epub 2012 Jan 5.